CDSCO issues revised Risk Based Classification of Cardiovascular and neurological medical devices; seeks stakeholders comments Dr. Divya Colin4 April 2025 6:00 PM ISTNew Delhi: Issuing a draft list of revised risk-based classification of cardiovascular and neurological devices, the Central Drugs Standard Control...
NPPA Fixes Ceiling Price of Ringer Lactate Injection Dr. Divya Colin3 April 2025 6:00 PM ISTNew Delhi: In line with the wholesale price index (WPI) at 1.74028% for the year 2024 over 2023, through a recent notification, the drug price...
Bayer Pharmaceutical Gets CDSCO Panel Nod To Import And Market Octocog alfa for hemophilia A Dr. Divya Colin2 April 2025 6:00 PM ISTNew Delhi: Granting the phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
NPPA Revises Ceiling Price of Tazofic Injection made by Gufic Biosciences Dr. Divya Colin1 April 2025 6:00 PM ISTNew Delhi: Through a recent notification, after considering the Wholesale Price Index (WPI) at 1.74028% for the year 2024 over 2023, the National...
Drug Alert: 47 Drug Samples Fail To Clear CDSCO Test, 1 Declared spurious Susmita Roy31 March 2025 2:08 PM ISTNew Delhi: With an aim to make stakeholders aware of the not-of-standard-quality (NSQ) batches identified in the market, in its latest drug alert, the...
Present relevant data about dose in patient: CDSCO Panel Tells Cipla on FDC of Torsemide Plus Spironolactone 5mg/25 mg Dr. Divya Colin30 March 2025 6:00 PM ISTNew Delhi: Citing that the data/literature presented by the drug major Cipla for the fixed-dose combination (FDC) drug Torsemide and Spironolactone (5...
NPPA Revises Ceiling Price of Coronary Stents Dr. Divya Colin29 March 2025 6:00 PM ISTNew Delhi: Through a recent notification, after considering the Wholesale Price Index (WPI) @ 1.74028% for the year 2024 over 2023, the National...
Drug Safety Alert: IPC Flags Adverse Reactions to Metronidazole, Luliconazole, Dalteparin, Gliclazide, and Tramadol Susmita Roy28 March 2025 6:00 PM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of March, has revealed adverse drug...
NPPA Allows 1.74% Price Hike for Essential Drugs, No Govt Approval Needed Farhat Nasim27 March 2025 7:48 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has permitted manufacturers to increase the Maximum Retail Price (MRP) of scheduled...
307 Cases of Drug Price Violations Surface, Big Pharma To Face Heat? Farhat Nasim26 March 2025 8:34 PM ISTNew Delhi: The issue of drug pricing violations has come under scrutiny, with the Parliamentary Standing Committee on Chemicals and Fertilizers...
Setback to Roche: Plea Against Natco on Risdiplam Patent Rejected by Delhi HC Farhat Nasim25 March 2025 5:31 PM ISTNew Delhi: In a major relief to Indian drugmaker Natco Pharma, the Delhi High Court has rejected an interim injunction plea filed by Swiss...
With Rs 3,788 Crore in Savings, Govt Eyes Adding More Drugs Under NLEM Farhat Nasim24 March 2025 5:40 PM IST"The arbitrary exclusion of essential medicines from price control must be addressed immediately," the Govt Panel said.
